The Future of Cognitive Enhancement As neuroscience advances, cognitive enhancement is shifting away from simple stimulation and toward strategies that support deeper biological foundations of brain health
Tip: Conduct monthly audits to spot documentation gaps early
If you have any known allergies or health concerns, let your provider know before treatment
Khalil R, Shata A, Abd El-Kader EM, Sharaf H, Abdo WS, Amin NA, Saber S (2020) Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38, and NF-B signaling
Cagrilintide is being explored as part of this approach, especially in combination with GLP-1 based therapies